Your browser doesn't support javascript.
loading
Natural and Synthetic Cannabinoids: Pharmacology, Uses, Adverse Drug Events, and Drug Interactions.
Brown, Joshua D; Rivera Rivera, Kevin J; Hernandez, Leilanie Y Crespo; Doenges, Matthew R; Auchey, India; Pham, Thanh; Goodin, Amie J.
Afiliación
  • Brown JD; Center for Drug Evaluation & Safety, University of Florida, Gainesville, Florida, USA.
  • Rivera Rivera KJ; Consortium for Medical Marijuana Clinical Outcomes Research, University of Florida, Gainesville, Florida, USA.
  • Hernandez LYC; Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • Doenges MR; University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • Auchey I; University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • Pham T; University of Florida College of Pharmacy, Gainesville, Florida, USA.
  • Goodin AJ; University of Florida College of Pharmacy, Gainesville, Florida, USA.
J Clin Pharmacol ; 61 Suppl 2: S37-S52, 2021 08.
Article en En | MEDLINE | ID: mdl-34396558
The purpose of this narrative review is to describe the current use environment of both natural and synthetic cannabinoids while providing context for cannabinoid chemistry and pharmacology. In addition to a long history of recreational and nonmedical use, natural cannabinoids are increasingly used as prescription products, through medical cannabis programs, and as consumer health products. Despite anecdotal safety evidence, cannabis and cannabinoids are pharmacologically complex and pose risks for adverse drug events and drug-drug interactions. Synthetic cannabinoids, particularly agonists of cannabinoid receptors, are more potent than natural cannabinoids and can lead to more severe reactions and medical emergencies. This review provides a summary of approved uses and an overview of mechanisms of action for adverse drug events with natural and synthetic cannabinoids. Clinical considerations for special populations that may be at heightened risk for drug-drug interactions and adverse drug events while using natural or synthetic cannabinoids are examined, and recommendations are provided.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cannabinoides Tipo de estudio: Guideline / Systematic_reviews Límite: Female / Humans / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: J Clin Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cannabinoides Tipo de estudio: Guideline / Systematic_reviews Límite: Female / Humans / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: J Clin Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido